Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by skys1on Feb 12, 2021 5:34pm
252 Views
Post# 32556378

RE:nice long weekend gift

RE:nice long weekend giftwounded knee, yesterday I posted that I believed this new interest and volume was due to the several new trial sites being opened up in the huge, well financed US medical sector. To date TLT has been hidden in a small Canadian exchange with a very poor reputation, little PR, and so bad that institutions can't even trade there. 
Now all of a sudden medical professionals and their associates in the huge US market are finding out about TLT's ACT and remarkable potential in the high reward area of cancer treatment. 
Total US volume today was 591K. Still it's a penny stock so we are only taljing about maybe $100K. That's only a couple doctors opening a position. If only $100K can move TLT 20%, just wait until word realy gets out and the CR% gets over 60. That;s when the real fireworks start.
<< Previous
Bullboard Posts
Next >>